OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
08/06/2026
Back to search
Official data from USPTO
C COAT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
08/06/2026
Trademark type
Combined
Nice classes
5, 10
Filing date
12/25/2024
Registration date
05/26/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/26/2026
Last transaction
08/06/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
IL
Examiner
HUSSAIN, TASNEEM
Law office
M90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized word "COAT" in dark teal with the letter "C" surrounded by a larger, curved "C" in teal.
Holders and representatives
Holders
LipoSphere Ltd.
Representatives
Jeffrey A. Smith Millen, White, Zelano & Branigan, P.C.
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Injectable preparations for the treatment of osteoarthritis; injectable solutions for medical purposesnamely a knee joint injectable liposomal solution for the treatment of osteoarthritis; lubricants for medical usenamely a joint injectable boundary lubricant for the treatment of osteoarthritis; injectable formulations for use in the treatment of joint cartilage and osteoarthritis; injectable preparations for improving the functionality of the knee joint of osteoarthritis patients; injectable preparations to improve knee joint functionality and pain.
Class 10
Medical device for the treatment of osteoarthritis; implantable medical device for the treatment of osteoarthritis; implantable medical device to improve the knee joint functionality and pain; medical device for improving functionality of the knee joint of osteoarthritis patients; an orthopedic medical device to improve joint functionality and pain.
Publications
History of USPTO decisions and trademark events.
21 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/20/2026
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/19/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/26/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
05/26/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/07/2026
PUBO
PUBLISHED FOR OPPOSITION
04/07/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/16/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/26/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/26/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/26/2026
RFNT
REFUSAL PROCESSED BY IB
11/15/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/28/2025
RFRR
REFUSAL PROCESSED BY MPU
10/28/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/10/2025
CNRT
NON-FINAL ACTION WRITTEN
09/09/2025
DOCK
ASSIGNED TO EXAMINER
09/08/2025
MAFR
APPLICATION FILING RECEIPT MAILED
09/07/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/07/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/20/2025
Continuous trademark protection
Get notified about every new filing that threatens C COAT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.